BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Intercept Blood System for plasma and platelets regulatory update

FDA granted Orphan Drug designation for Cerus' Intercept Blood System for plasma to treat thrombotic thrombocytopenic purpura (TTP). The system, which...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >